1. Home
  2. NTRS vs KVUE Comparison

NTRS vs KVUE Comparison

Compare NTRS & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Trust Corporation

NTRS

Northern Trust Corporation

HOLD

Current Price

$160.47

Market Cap

31.8B

Sector

Finance

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.63

Market Cap

33.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRS
KVUE
Founded
1889
2022
Country
United States
United States
Employees
23800
N/A
Industry
Major Banks
Specialty Chemicals
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
33.7B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
NTRS
KVUE
Price
$160.47
$17.63
Analyst Decision
Hold
Buy
Analyst Count
12
11
Target Price
$163.55
$19.45
AVG Volume (30 Days)
1.1M
14.9M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
1.94%
4.82%
EPS Growth
N/A
40.74
EPS
N/A
0.25
Revenue
N/A
$15,124,000,000.00
Revenue This Year
$8.40
$4.85
Revenue Next Year
$4.13
$2.63
P/E Ratio
$16.88
$71.34
Revenue Growth
N/A
N/A
52 Week Low
$104.09
$14.02
52 Week High
$173.19
$24.60

Technical Indicators

Market Signals
Indicator
NTRS
KVUE
Relative Strength Index (RSI) 54.09 53.02
Support Level $135.49 $17.20
Resistance Level $173.19 $17.84
Average True Range (ATR) 4.38 0.33
MACD -1.25 0.04
Stochastic Oscillator 7.26 68.75

Price Performance

Historical Comparison
NTRS
KVUE

About NTRS Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2025, Northern Trust had assets under custody or administration of $18.7 trillion and assets under management of $1.8 trillion.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: